A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/255 (2006.01) A61K 31/4015 (2006.01) A61K 31/44 (2006.01) A61K 31/4412 (2006.01)
Patent
CA 2323490
Certain simple chemical agents, referred to herein as nitrone related therapeutics or "NRTs", when administered to a patient susceptible to neovascularization (angiogenesis), can intervene and inhibit the disease's progress. Methods for therapeutically and prophylactically inhibiting angiogenesis by administering one or more NRTs are disclosed as are pharmaceutical compositions for use in such methods of treating. NRTs useful in these compositions and therapeutic methods are also disclosed.
Certains agents chimiques simples, désignés en tant qu'agents thérapeutiques apparentés à nitrone ou "NRT", quand on les administre à un patient susceptible de néovascularisation (angiogenèse), peuvent intervenir et inhiber la progression de la maladie. L'invention concerne des procédés servant à inhiber l'angiogenèse, sur le plan thérapeutique et prophylactique, par administration d'un ou de plusieurs NRT, ainsi que des compositions pharmaceutiques mises en application dans ces procédés de traitement. Elle concerne également des NRT utiles pour ces compositions et ces procédés thérapeutiques.
Narducy Kenneth W.
Waterbury Lowell D.
Wilcox Allan L.
Centaur Pharmaceuticals Inc.
Fetherstonhaugh & Co.
Renovis Inc.
LandOfFree
Inhibition of angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1643803